With the approval of the Can Tho City Department of Health, on the afternoon of June 3, 2022, Can Tho Cancer Hospital, in collaboration with the Department of Anesthesiology and Intensive Care of Can Tho University of Medicine and Pharmacy, and Thai Van Phong Medical Equipment Company Limited, successfully organized a CME-accredited workshop on the topic “Application of Subcutaneous Port Placement Technique in Chemotherapy and Pain Management Infusion.” The conference took place both in-person at Conference Room CS1 and online, connecting with invited guests from cancer departments in Can Tho and the Mekong Delta region.
The conference was attended by the chairman, Dr. Nguyen Truong Giang, the Director of Can Tho Cancer Hospital, Dr. Le Tien Manh, Deputy Director of Can Tho Cancer Hospital, and the speakers included Dr. Mai Van Nha, Head of Internal Medicine Department 1 at Can Tho Cancer Hospital, MSc. Dr. Vu Van Kim Long, Department of Anesthesiology and Intensive Care of Can Tho University of Medicine and Pharmacy, and MSc. Dr. Nguyen Chi Cuong from Medic Medical Center in Ho Chi Minh City. The workshop was coordinated by Thai Van Phong Medical Equipment Company Limited.
The seminar presented clinical diseases and practical techniques of subcutaneous infusion port placement and management of extravasation in patients at the GMHS department. Through live video streaming, the audience in the conference hall witnessed the process of performing the technique and actively participated in the discussion.
The subcutaneous infusion port placement technique involves inserting a catheter into the central vein under the guidance of ultrasound, which is then connected to a subcutaneous infusion port placed at an appropriate location. This process aims to achieve long-term central venous infusion without the need for repeated blood sampling. This technique is commonly used for cancer patients undergoing chemotherapy. Some advantages of this technique include replacing traditional needle-based intravenous access, reducing the risk of infection, ease of care, and long-term use.
Extravasation is a common complication in chemotherapy when using peripheral intravenous access for infusion. At the extravasation site, the concentration of chemotherapy drugs is often high, causing irritation or even damage to the surrounding tissues. According to the Ministry of Health, the incidence of extravasation complications in conventional chemotherapy ranges from 1% to 7%. However, increasing awareness of extravasation complications and improving infusion techniques to minimize harm and complications for patients is crucial.
